Glaukos Total Liabilities and Share Holders Equity 2014-2024 | GKOS

Glaukos total liabilities and share holders equity from 2014 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Glaukos total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.927B, a 2.33% decline year-over-year.
  • Glaukos total liabilities and share holders equity for 2023 was $0.94B, a 6.18% decline from 2022.
  • Glaukos total liabilities and share holders equity for 2022 was $1.002B, a 4.51% decline from 2021.
  • Glaukos total liabilities and share holders equity for 2021 was $1.05B, a 4.4% increase from 2020.
Glaukos Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $940
2022 $1,002
2021 $1,050
2020 $1,006
2019 $818
2018 $207
2017 $166
2016 $134
2015 $117
2014 $26
2013 $31
Glaukos Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $927
2024-06-30 $920
2024-03-31 $933
2023-12-31 $940
2023-09-30 $949
2023-06-30 $957
2023-03-31 $973
2022-12-31 $1,002
2022-09-30 $1,008
2022-06-30 $1,031
2022-03-31 $1,052
2021-12-31 $1,050
2021-09-30 $1,064
2021-06-30 $1,044
2021-03-31 $1,023
2020-12-31 $1,006
2020-09-30 $995
2020-06-30 $996
2020-03-31 $780
2019-12-31 $818
2019-09-30 $307
2019-06-30 $302
2019-03-31 $228
2018-12-31 $207
2018-09-30 $191
2018-06-30 $171
2018-03-31 $163
2017-12-31 $166
2017-09-30 $153
2017-06-30 $146
2017-03-31 $138
2016-12-31 $134
2016-09-30 $129
2016-06-30 $124
2016-03-31 $116
2015-12-31 $117
2015-09-30 $118
2015-06-30 $128
2015-03-31 $28
2014-12-31 $26
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.765B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.408B 24.08
Intuitive Surgical (ISRG) United States $196.120B 102.54
Alcon (ALC) Switzerland $42.207B 28.24
Edwards Lifesciences (EW) United States $41.510B 26.36
IQVIA Holdings (IQV) United States $35.864B 19.76
IDEXX Laboratories (IDXX) United States $34.273B 40.36
DexCom (DXCM) United States $29.084B 43.80
Waters (WAT) United States $21.880B 32.35
STERIS (STE) Ireland $21.298B 24.52
SONOVA HOLDING (SONVY) Switzerland $20.458B 0.00
Hologic (HOLX) United States $18.284B 19.29
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 13.24
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Globus Medical (GMED) United States $11.562B 29.28
Penumbra (PEN) United States $9.230B 90.41
Masimo (MASI) United States $9.055B 43.81
Teleflex (TFX) United States $8.854B 14.12
PROCEPT BioRobotics (PRCT) United States $4.929B 0.00
Integer Holdings (ITGR) United States $4.558B 25.83
Veracyte (VCYT) United States $3.018B 90.56
Inari Medical (NARI) United States $2.913B 0.00
LivaNova (LIVN) United Kingdom $2.807B 16.21
TransMedics (TMDX) United States $2.663B 84.40
Nihon Kohden (NHNKY) Japan $2.428B 18.44
Elekta AB (EKTAY) Sweden $2.125B 17.31
Tandem Diabetes Care (TNDM) United States $2.019B 0.00
RxSight (RXST) United States $1.816B 0.00
Integra LifeSciences Holdings (IART) United States $1.775B 9.27
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $1.175B 77.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $0.992B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.828B 14.08
ORTHOFIX MEDICAL INC (OFIX) United States $0.714B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.641B 0.00
AxoGen (AXGN) United States $0.577B 0.00
Mesa Laboratories (MLAB) United States $0.548B 12.91
SiBone (SIBN) United States $0.515B 0.00
Treace Medical Concepts (TMCI) United States $0.495B 0.00
Pacific Biosciences Of California (PACB) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.483B 32.40
Tactile Systems Technology (TCMD) United States $0.383B 20.70
CVRx (CVRX) United States $0.358B 0.00
Delcath Systems (DCTH) United States $0.315B 0.00
ClearPoint Neuro (CLPT) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
NeuroPace (NPCE) United States $0.269B 0.00
Inogen (INGN) United States $0.219B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Nevro (NVRO) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.150B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.67
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.087B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Covalon Technologies (CVALF) Canada $0.077B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Vicarious Surgical (RBOT) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Neuronetics (STIM) United States $0.025B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00